Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Background
Hemostasis is an essential physiological process that keeps blood within your blood vessels, preventing or halting blood flow when a blood vessel is injured. It constitutes the initial wound healing process and significantly contributes to maintaining good health.Â
Primary hemostasis is the initial step of blood clotting that occurs just after injury to blood vessels.Â
Primary hemostasis is the first step in preventing immediate bleeding following injury by providing a temporary seal of the vessel until secondary hemostasis, the coagulation cascade, further stabilizes the clot.Â
Stages of hemostasisÂ
Epidemiology
Vascular Spasm (Vasoconstriction):Â
A blood vessel wall, once damaged, provokes a reflexive contraction of the smooth muscle to reduce blood flow and minimize blood loss.Â
Platelet Plug Formation-Primary Hemostasis:Â
Because of exposure to collagen and other products from vessel wall injury, platelets are activated.Â
They become sticky and hence attach themselves to the site of injury; thus, plugging the site/area together for bleeding to stop.Â
Coagulation-Secondary Hemostasis:Â
The activation of the coagulation factors leads to a cascade of enzymatic reactions that eventually produce fibrin.Â
The formed fibrin creates a mesh around the platelet plug, encapsulating and thereby stabilizing it to form a more stable clot.Â
Clot retraction and Repair:Â
Upon clot formation, the platelets contract to reduce the size of the clot and pack it down.Â
As the vessel wall heals, fibrinolysis starts breaking down the clot, and eventually, the vessel’s patency is restored when the vessel wall is adequately healed.Â
Anatomy
Pathophysiology
Trauma: Physical injury resulting in blood vessel damage.Â
Coagulation Disorders: Diseases caused by clotting factors or platelet malfunction, such as hemophilia or von Willebrand disease.Â
Medicines: Certain medications may interfere with platelet function or clotting cascade.Â
Autoimmune Disorders: Examples include diseases wherein the body attacks its clotting factors.Â
Genetic Disorders: Inherited disorders affecting clotting factors or platelets.Â
Abnormalities of Vessels: Weakened blood vessel walls increase their propensity to bleed.Â
Infections: Some infections may be associated with abnormal clotting or bleeding.Â
Etiology
Genetics
Prognostic Factors
Clinical History
Physical Examination
Coagulation factor assaysÂ
Prothrombin time and activated partial prothrombin time Â
Platelet count Â
Age group
Associated comorbidity
CoagulopathiesÂ
Liver DiseaseÂ
Platelet DisordersÂ
MedicationÂ
Trauma or SurgeryÂ
Vascular DisordersÂ
Associated activity
Acuity of presentation
Differential Diagnoses
Platelet DisordersÂ
Coagulation Factor DeficienciesÂ
Vascular DisordersÂ
Inherited DisordersÂ
 Acquired DisordersÂ
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
use-of-non-pharmacological-approach-for-hemostasis
Effectiveness of Antifibrinolytics in hemostasis
Role of clotting factor and platelet stimulants in hemostasis
Clotting factor and platelet stimulants: These are medications that enhance the ability to form and maintain blood clots:Â
Desmopressin: This medication stimulates the release of von Willebrand factor and factor VIII.Â
Effectiveness of Hemostatic Agents in hemostasis
role-of-intervention-with-procedure-in-hemostasis
role-of-management-in-hemostasis
Medication
For Evicel
Spray onto the surface of bleeding tissues in brief bursts about 0.1 to 0.2 ml and if the hemostatic outcome is incomplete then apply a another coat
If the maximum area to be sealed is 20 cm², then use around 2 ml
If the maximum area to be sealed is 40 cm², then use around 4 ml
If the maximum area to be sealed is 100 cm², then use around 10 ml
For TachoSil Patch
If not more than 7 patches are to be applied, then apply patch size of about 9.5 cm x 4.8 cm
If not more than 14 patches are to be applied, then apply patch size of about 4.8 cm x 4.8 cm
If not more than 42 patches are to be applied, then apply patch size of about 3.0 cm x 2.5 cm
For Tisseel VH
If the maximum area to be sealed is 8 cm² through a cannula then use around 2 ml
If the maximum area to be sealed is 16 cm² through a cannula then use around 4 ml
If the maximum area to be sealed is 40 cm² through a cannula then use around 10 ml
To address bleeding, First, pour a small quantity of the solution into a disposable cup or clean dappen dish for control of hemorrhage
Soak a retraction cord in the solution and carefully place it in the gingival sulcus using a cord-packing instrument during restorative impressions
In cases of minor bleeding unrelated to restorative impressions, take a cotton pellet and soak it in the solution
Gently place the soaked cotton pellet on the affected area for a few seconds, Afterward, rinse the area with water
For Evicel
Safety and efficacy not determined in less than six years old
≥6 months:
Spray onto the surface of bleeding tissues in brief bursts about 0.1 to 0.2 ml and if the hemostatic outcome is incomplete then apply a another coat
If the maximum area to be sealed is 20 cm², then use around 2 ml
If the maximum area to be sealed is 20 cm², then use around 2 ml
If the maximum area to be sealed is 40 cm², then use around 4 ml
If the maximum area to be sealed is 100 cm², then use around 10 ml
For Tisseel
For <1 month: Safety and efficacy not determined
For ≥1 month:
If the maximum area to be sealed is 8 cm² through a cannula then use around 2 ml
If the maximum area to be sealed is 16 cm² through a cannula then use around 4 ml
If the maximum area to be sealed is 40 cm² through a cannula then use around 10 ml
Future Trends
Hemostasis is an essential physiological process that keeps blood within your blood vessels, preventing or halting blood flow when a blood vessel is injured. It constitutes the initial wound healing process and significantly contributes to maintaining good health.Â
Primary hemostasis is the initial step of blood clotting that occurs just after injury to blood vessels.Â
Primary hemostasis is the first step in preventing immediate bleeding following injury by providing a temporary seal of the vessel until secondary hemostasis, the coagulation cascade, further stabilizes the clot.Â
Stages of hemostasisÂ
Vascular Spasm (Vasoconstriction):Â
A blood vessel wall, once damaged, provokes a reflexive contraction of the smooth muscle to reduce blood flow and minimize blood loss.Â
Platelet Plug Formation-Primary Hemostasis:Â
Because of exposure to collagen and other products from vessel wall injury, platelets are activated.Â
They become sticky and hence attach themselves to the site of injury; thus, plugging the site/area together for bleeding to stop.Â
Coagulation-Secondary Hemostasis:Â
The activation of the coagulation factors leads to a cascade of enzymatic reactions that eventually produce fibrin.Â
The formed fibrin creates a mesh around the platelet plug, encapsulating and thereby stabilizing it to form a more stable clot.Â
Clot retraction and Repair:Â
Upon clot formation, the platelets contract to reduce the size of the clot and pack it down.Â
As the vessel wall heals, fibrinolysis starts breaking down the clot, and eventually, the vessel’s patency is restored when the vessel wall is adequately healed.Â
Trauma: Physical injury resulting in blood vessel damage.Â
Coagulation Disorders: Diseases caused by clotting factors or platelet malfunction, such as hemophilia or von Willebrand disease.Â
Medicines: Certain medications may interfere with platelet function or clotting cascade.Â
Autoimmune Disorders: Examples include diseases wherein the body attacks its clotting factors.Â
Genetic Disorders: Inherited disorders affecting clotting factors or platelets.Â
Abnormalities of Vessels: Weakened blood vessel walls increase their propensity to bleed.Â
Infections: Some infections may be associated with abnormal clotting or bleeding.Â
Coagulation factor assaysÂ
Prothrombin time and activated partial prothrombin time Â
Platelet count Â
CoagulopathiesÂ
Liver DiseaseÂ
Platelet DisordersÂ
MedicationÂ
Trauma or SurgeryÂ
Vascular DisordersÂ
Platelet DisordersÂ
Coagulation Factor DeficienciesÂ
Vascular DisordersÂ
Inherited DisordersÂ
 Acquired DisordersÂ
Hematology
Hematology
Hematology
Clotting factor and platelet stimulants: These are medications that enhance the ability to form and maintain blood clots:Â
Desmopressin: This medication stimulates the release of von Willebrand factor and factor VIII.Â
Hematology
Hematology
Hematology
Hemostasis is an essential physiological process that keeps blood within your blood vessels, preventing or halting blood flow when a blood vessel is injured. It constitutes the initial wound healing process and significantly contributes to maintaining good health.Â
Primary hemostasis is the initial step of blood clotting that occurs just after injury to blood vessels.Â
Primary hemostasis is the first step in preventing immediate bleeding following injury by providing a temporary seal of the vessel until secondary hemostasis, the coagulation cascade, further stabilizes the clot.Â
Stages of hemostasisÂ
Vascular Spasm (Vasoconstriction):Â
A blood vessel wall, once damaged, provokes a reflexive contraction of the smooth muscle to reduce blood flow and minimize blood loss.Â
Platelet Plug Formation-Primary Hemostasis:Â
Because of exposure to collagen and other products from vessel wall injury, platelets are activated.Â
They become sticky and hence attach themselves to the site of injury; thus, plugging the site/area together for bleeding to stop.Â
Coagulation-Secondary Hemostasis:Â
The activation of the coagulation factors leads to a cascade of enzymatic reactions that eventually produce fibrin.Â
The formed fibrin creates a mesh around the platelet plug, encapsulating and thereby stabilizing it to form a more stable clot.Â
Clot retraction and Repair:Â
Upon clot formation, the platelets contract to reduce the size of the clot and pack it down.Â
As the vessel wall heals, fibrinolysis starts breaking down the clot, and eventually, the vessel’s patency is restored when the vessel wall is adequately healed.Â
Trauma: Physical injury resulting in blood vessel damage.Â
Coagulation Disorders: Diseases caused by clotting factors or platelet malfunction, such as hemophilia or von Willebrand disease.Â
Medicines: Certain medications may interfere with platelet function or clotting cascade.Â
Autoimmune Disorders: Examples include diseases wherein the body attacks its clotting factors.Â
Genetic Disorders: Inherited disorders affecting clotting factors or platelets.Â
Abnormalities of Vessels: Weakened blood vessel walls increase their propensity to bleed.Â
Infections: Some infections may be associated with abnormal clotting or bleeding.Â
Coagulation factor assaysÂ
Prothrombin time and activated partial prothrombin time Â
Platelet count Â
CoagulopathiesÂ
Liver DiseaseÂ
Platelet DisordersÂ
MedicationÂ
Trauma or SurgeryÂ
Vascular DisordersÂ
Platelet DisordersÂ
Coagulation Factor DeficienciesÂ
Vascular DisordersÂ
Inherited DisordersÂ
 Acquired DisordersÂ
Hematology
Hematology
Hematology
Clotting factor and platelet stimulants: These are medications that enhance the ability to form and maintain blood clots:Â
Desmopressin: This medication stimulates the release of von Willebrand factor and factor VIII.Â
Hematology
Hematology
Hematology

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
